scholarly article | Q13442814 |
P50 | author | Larry E. Miller | Q38601507 |
P433 | issue | 1 | |
P304 | page(s) | 25-30 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Journal of the Academy of Nutrition and Dietetics | Q6296079 |
P1476 | title | Lorcaserin for weight loss: insights into US Food and Drug Administration approval | |
P478 | volume | 113 |
Q38770244 | Endogenous 5-HT2C Receptors Phosphorylate the cAMP Response Element Binding Protein via Protein Kinase C-Promoted Activation of Extracellular-Regulated Kinases-1/2 in Hypothalamic mHypoA-2/10 Cells |
Q92311971 | Intraperitoneal administration of follistatin promotes adipocyte browning in high-fat diet-induced obese mice |
Q36206061 | Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review |
Q38308961 | Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications |
Q41888121 | The next generation of obesity treatments: beyond suppressing appetite |
Search more.